Lupin Limited (BOM:500257)
India
· Delayed Price · Currency is INR 1,959.85
-29.35 (-1.48%)
At close: Aug 14, 2025
Lupin Employees
Lupin had 24,006 employees as of March 31, 2025. The number of employees increased by 2,138 or 9.78% compared to the previous year.
Employees
24,006
Change (1Y)
2,138
Growth (1Y)
9.78%
Revenue / Employee
9.74M INR
Profits / Employee
1.54M INR
Market Cap
895.16B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Reliance Industries | 403,303 |
| HDFC Bank | 214,521 |
| Bharti Airtel | 13,593 |
| Tata Consultancy Services | 607,979 |
| ICICI Bank | 182,665 |
| State Bank of India | 236,226 |
| Infosys | 323,578 |
| Hindustan Unilever | 18,802 |
Lupin News
- 4 weeks ago - Lupin’s Pithampur Unit-3 gets 3 observations from US FDA after inspection - Business Upturn
- 4 weeks ago - Lupin launches generic Lotemax ophthalmic suspension in the U.S. market - Business Upturn
- 6 weeks ago - Lupin launches Ipratropium Bromide Nasal Solution (Nasal Spray) in the US market - Business Upturn
- 6 weeks ago - Lupin gets USFDA nod for Loteprednol Etabonate Ophthalmic Gel; Eligible for 180-day generic exclusivity - Business Upturn
- 6 weeks ago - Lupin carves out LupinLife into separate consumer healthcare subsidiary to focus on OTC consumer wellness market - Business Upturn
- 2 months ago - Lupin shares in focus as company signs respiratory drug deal in China with Sino Universal - Business Upturn
- 2 months ago - Lupin gets U.S. FDA tentative approval for Generic Oxcarbazepine ER Tablets - Business Upturn
- 2 months ago - Lupin to present Phase 1 data on LNP7457 cancer drug at ASCO 2025 - Business Upturn